Tag: Cancer: Leukemia
Genomic Approach Could Aid Risk Stratification in Adults With AML
Persistent leukemia-linked mutations in remission samples tied to increased relapse, worse survival
Medicare Will Cover Expensive New Leukemia Medication
Amgen's Blincyto costs about $178,000 for a standard course of treatment
Tyrosine Kinase Inhibitors Seem Safe in CML With CKD
In these patients, no further decline in GFR, regardless of TKI used
New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
Breastfeeding Tied to Lower Odds of Childhood Leukemia
One more potential benefit for breastfed babies, research suggests
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Increased Risk of Cancer Seen for Offspring of Older Fathers
Higher risk for blood and immune system cancers
Genetic Mutations Found in Leukemia Rise With Age
But just having cancer-linked DNA doesn't mean the disease will develop, study authors stress
Researchers Examine Etiology of Ibrutinib Discontinuation in CLL
Poor prognosis after discontinuation for disease progression, especially Richter's transformation
SNP Linked to Vincristine-Related Neuropathy in ALL
SNP in promoter region of CEP72 gene linked to risk and severity of neuropathy in children with ALL
